Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Plaivana is a topical herbal cream containing a 14% extract of Plai (*Zingiber cassumunar* Roxb.), a plant in the ginger family traditionally used in Thai medicine. The product is standardized to contain active compounds such as (E)-1-(3,4-dimethoxyphenyl) butadiene (DMPBD), sabinene, and terpinen-4-ol. It exhibits potent anti-inflammatory and analgesic properties by inhibiting cyclooxygenase-2 (COX-2) activity, suppressing nitric oxide (NO) production, and scavenging reactive oxygen species like hydrogen peroxide. Plaivana is primarily indicated for the symptomatic relief of pain associated with knee osteoarthritis and acute musculoskeletal injuries such as athletic ankle sprains, offering a topical alternative to systemic non-steroidal anti-inflammatory drugs (NSAIDs).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Plaivana.